Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 SEK)

NET PROFIT (x1000 SEK)

EMPLOYEES

Share

GHN Pharma AB

Closing information (x1000 SEK)

Closing information 2024/12 (consolidated) 2023/12 2022/12
Turnover 161,968 Less Arrow 1,997 Less Arrow 296
Financial expenses 174 Less Arrow 11 More Arrow 2,436
Earnings before taxes 29,140 Less Arrow 5,290 Less Arrow -2,975
EBITDA 20,211 Less Arrow -60 Less Arrow -2,014
Total assets 171,576 Less Arrow 95,545 Less Arrow 90,619
Current assets 70,672 Less Arrow 2,969 Less Arrow 2,403
Current liabilities 31,247 Less Arrow 846 Less Arrow 210
Equity capital 130,861 Less Arrow 94,699 Less Arrow 90,409
- share capital 412 Equal arrow 412 Equal arrow 412
Employees (average) 7 Less Arrow 2 Equal arrow 2

Financial ratios

Fiscal year 2024/12 (consolidated) 2023/12 2022/12
Solvency 76.3% More Arrow 99.1% More Arrow 99.8%
Turnover per employee 23,138 Less Arrow 998 Less Arrow 148
Profit as a percentage of turnover 18.0% More Arrow 264.9% Less Arrow -1005.1%
Return on assets (ROA) 17.1% Less Arrow 5.5% Less Arrow -0.6%
Current ratio 226.2% More Arrow 350.9% More Arrow 1144.3%
Return on equity (ROE) 22.3% Less Arrow 5.6% Less Arrow -3.3%
Change turnover
Change turnover % 575% Less Arrow -95%
Chg. No. of employees
Chg. No. of employees % 0% Equal arrow 0%

Total value of public sale

Fiscal year 2024/12 (consolidated) 2023/12 2022/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.